NCT02659254View on ClinicalTrials.gov

A First-in-Man Study of the Firesorb BVS (FUTURE-I)

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

March 31, 2021

Conditions
Coronary Artery Disease
Interventions
DEVICE

Sirolimus Target Eluting Bioresorbable Vascular Scaffold

Implantation of the Sirolimus Target Eluting Bioresorbable Vascular Scaffold

Trial Locations (1)

100037

Fu Wai Hospital, Beijing

All Listed Sponsors
lead

Shanghai MicroPort Medical (Group) Co., Ltd.

INDUSTRY

NCT02659254 - A First-in-Man Study of the Firesorb BVS (FUTURE-I) | Biotech Hunter | Biotech Hunter